{"id":1110,"date":"2019-12-04T14:23:55","date_gmt":"2019-12-04T14:23:55","guid":{"rendered":"https:\/\/www.competitionlawyers.co.uk\/blog\/?p=1110"},"modified":"2019-12-04T14:23:55","modified_gmt":"2019-12-04T14:23:55","slug":"provisional-finding-in-drug-price-hikes-case","status":"publish","type":"post","link":"https:\/\/www.competitionlawyers.co.uk\/blog\/provisional-finding-in-drug-price-hikes-case","title":{"rendered":"Provisional finding in drug price hikes case"},"content":{"rendered":"

The UK\u2019s competition regulator has made a provisional finding in the longstanding investigation into drug price hikes, and the outcome is damning.<\/p>\n

Issues surrounding pharmaceutical competition breaches are numerous and serious. At the end of the day, the consumer in these cases is patients and the NHS; that\u2019s our tax money.<\/p>\n

Any infringement of vital competition laws when it comes to medical matters should always lead to significant punishments, and the work of the CMA (Competition and Markets Authority) in this area is incredibly important. The provisional finding in this matter accompanies an admission from one of the companies involved as well.<\/p>\n

<\/p>\n

Statement of objections issued<\/strong><\/h3>\n

The CMA issued a statement of objection in October 2019 relating to their investigations into alleged drug price hikes in the UK.<\/p>\n

The provisional view is that pharmaceutical company Aspen allegedly agreed to make unlawful payments to two other companies in order for them to effectively stay out of the market. This could then allow them to keep prices – and therefore profits – high with there being no competition to have to deal with<\/p>\n

The companies who are believed to have received payments are Amilco and Tiofarma.<\/p>\n

Impact of the drug price hikes case<\/strong><\/h3>\n

The impact of drug price hikes can mean that patients and the NHS are having to pay more for their medication. In this case, the drug in question is fludrocortisone acetate tablets, which is a prescription-only medication.<\/p>\n

It\u2019s alleged that the three companies signed an illegal agreement in order to allow Aspen to protect a\u00a0 monopoly in relation to the supply of the drug to the NHS. It\u2019s also understood to have allowed them to hike the price of the drug up by 1,800%,<\/p>\n

The alleged agreements between them reportedly allowed Tiofarma to be the sole manufacturer for direct sale in the UK, and Amilco allegedly received a 30% share of the increased prices that Aspen charged. These kinds of arrangements are in breach of vital competition law<\/strong><\/a>, and when infringements involve our NHS and taxpayers\u2019 money, it\u2019s harder to stomach.<\/p>\n

Aspen\u2019s admission <\/strong><\/h3>\n

The statement of objections issued in the drug price hikes case actually follows an admission from Aspen that it took part in allegedly anti-competitive agreements.<\/p>\n

Where the CMA ultimately reaches a solid conclusion of an infringement, it’s understood that Aspen has already agreed to pay a maximum fine of \u00a32.1m. As of yet, no admissions have been received from Amilco and Tiofarma.<\/p>\n

There are also additional related commitments to pay the NHS \u00a38m and to ensure that there will be at least two suppliers of fludrocortisone in the UK in the future.<\/p>\n","protected":false},"excerpt":{"rendered":"

The UK\u2019s competition regulator has made a provisional finding in the longstanding investigation into drug price hikes, and the outcome is damning. Issues surrounding pharmaceutical competition breaches are numerous and serious. At the end of the day, the consumer in these cases is patients and the NHS; that\u2019s our tax money. Any infringement of vital … Continue reading Provisional finding in drug price hikes case<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":90,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"jetpack_post_was_ever_published":false,"_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[58,10,8],"tags":[2,15,64,45,50,28],"class_list":["post-1110","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-healthcare","category-investigations","category-price-hikes","tag-cma","tag-competition-law","tag-drugs","tag-investigations","tag-pharmaceuticals","tag-pricing"],"yoast_head":"\nProvisional finding in drug price hikes case - Competition Lawyers<\/title>\n<meta name=\"description\" content=\"The UK\u2019s competition regulator has made a provisional finding in the longstanding investigation into drug price hikes, and the outcome is damning.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.competitionlawyers.co.uk\/blog\/provisional-finding-in-drug-price-hikes-case\" \/>\n<meta property=\"og:locale\" content=\"en_GB\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Provisional finding in drug price hikes case - Competition Lawyers\" \/>\n<meta property=\"og:description\" content=\"The UK\u2019s competition regulator has made a provisional finding in the longstanding investigation into drug price hikes, and the outcome is damning.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.competitionlawyers.co.uk\/blog\/provisional-finding-in-drug-price-hikes-case\" \/>\n<meta property=\"og:site_name\" content=\"Competition Lawyers\" \/>\n<meta property=\"article:published_time\" content=\"2019-12-04T14:23:55+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/i2.wp.com\/www.competitionlawyers.co.uk\/blog\/wp-content\/uploads\/2016\/08\/pharmacy_merger_report.png?fit=725%2C250&ssl=1\" \/>\n\t<meta property=\"og:image:width\" content=\"725\" \/>\n\t<meta property=\"og:image:height\" content=\"250\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Author\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@Matt\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Author\" \/>\n\t<meta name=\"twitter:label2\" content=\"Estimated reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.competitionlawyers.co.uk\\\/blog\\\/provisional-finding-in-drug-price-hikes-case#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.competitionlawyers.co.uk\\\/blog\\\/provisional-finding-in-drug-price-hikes-case\"},\"author\":{\"name\":\"Author\",\"@id\":\"https:\\\/\\\/www.competitionlawyers.co.uk\\\/blog\\\/#\\\/schema\\\/person\\\/32c18f906b91fed8634e71af54b2a301\"},\"headline\":\"Provisional finding in drug price hikes case\",\"datePublished\":\"2019-12-04T14:23:55+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.competitionlawyers.co.uk\\\/blog\\\/provisional-finding-in-drug-price-hikes-case\"},\"wordCount\":447,\"commentCount\":0,\"image\":{\"@id\":\"https:\\\/\\\/www.competitionlawyers.co.uk\\\/blog\\\/provisional-finding-in-drug-price-hikes-case#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/i0.wp.com\\\/www.competitionlawyers.co.uk\\\/blog\\\/wp-content\\\/uploads\\\/2016\\\/08\\\/pharmacy_merger_report.png?fit=725%2C250&ssl=1\",\"keywords\":[\"cma\",\"competition law\",\"drugs\",\"investigations\",\"Pharmaceuticals\",\"pricing\"],\"articleSection\":[\"Healthcare\",\"Investigations\",\"Price Hikes\"],\"inLanguage\":\"en-GB\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/www.competitionlawyers.co.uk\\\/blog\\\/provisional-finding-in-drug-price-hikes-case#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.competitionlawyers.co.uk\\\/blog\\\/provisional-finding-in-drug-price-hikes-case\",\"url\":\"https:\\\/\\\/www.competitionlawyers.co.uk\\\/blog\\\/provisional-finding-in-drug-price-hikes-case\",\"name\":\"Provisional finding in drug price hikes case - Competition Lawyers\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.competitionlawyers.co.uk\\\/blog\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.competitionlawyers.co.uk\\\/blog\\\/provisional-finding-in-drug-price-hikes-case#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.competitionlawyers.co.uk\\\/blog\\\/provisional-finding-in-drug-price-hikes-case#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/i0.wp.com\\\/www.competitionlawyers.co.uk\\\/blog\\\/wp-content\\\/uploads\\\/2016\\\/08\\\/pharmacy_merger_report.png?fit=725%2C250&ssl=1\",\"datePublished\":\"2019-12-04T14:23:55+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.competitionlawyers.co.uk\\\/blog\\\/#\\\/schema\\\/person\\\/32c18f906b91fed8634e71af54b2a301\"},\"description\":\"The UK\u2019s competition regulator has made a provisional finding in the longstanding investigation into drug price hikes, and the outcome is damning.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.competitionlawyers.co.uk\\\/blog\\\/provisional-finding-in-drug-price-hikes-case#breadcrumb\"},\"inLanguage\":\"en-GB\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.competitionlawyers.co.uk\\\/blog\\\/provisional-finding-in-drug-price-hikes-case\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\\\/\\\/www.competitionlawyers.co.uk\\\/blog\\\/provisional-finding-in-drug-price-hikes-case#primaryimage\",\"url\":\"https:\\\/\\\/i0.wp.com\\\/www.competitionlawyers.co.uk\\\/blog\\\/wp-content\\\/uploads\\\/2016\\\/08\\\/pharmacy_merger_report.png?fit=725%2C250&ssl=1\",\"contentUrl\":\"https:\\\/\\\/i0.wp.com\\\/www.competitionlawyers.co.uk\\\/blog\\\/wp-content\\\/uploads\\\/2016\\\/08\\\/pharmacy_merger_report.png?fit=725%2C250&ssl=1\",\"width\":725,\"height\":250,\"caption\":\"Pharmaceutical abuse\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.competitionlawyers.co.uk\\\/blog\\\/provisional-finding-in-drug-price-hikes-case#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.competitionlawyers.co.uk\\\/blog\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Provisional finding in drug price hikes case\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.competitionlawyers.co.uk\\\/blog\\\/#website\",\"url\":\"https:\\\/\\\/www.competitionlawyers.co.uk\\\/blog\\\/\",\"name\":\"Competition Lawyers\",\"description\":\"Latest Legal News, Cases & Articles\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.competitionlawyers.co.uk\\\/blog\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-GB\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.competitionlawyers.co.uk\\\/blog\\\/#\\\/schema\\\/person\\\/32c18f906b91fed8634e71af54b2a301\",\"name\":\"Author\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/6df762ce646241b4e07c2c84d0016582f85c0b3c6f2ce06d0eb5d9aed612cc4e?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/6df762ce646241b4e07c2c84d0016582f85c0b3c6f2ce06d0eb5d9aed612cc4e?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/6df762ce646241b4e07c2c84d0016582f85c0b3c6f2ce06d0eb5d9aed612cc4e?s=96&d=mm&r=g\",\"caption\":\"Author\"},\"sameAs\":[\"https:\\\/\\\/x.com\\\/Matt\"],\"url\":\"https:\\\/\\\/www.competitionlawyers.co.uk\\\/blog\\\/author\\\/matt\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Provisional finding in drug price hikes case - Competition Lawyers","description":"The UK\u2019s competition regulator has made a provisional finding in the longstanding investigation into drug price hikes, and the outcome is damning.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.competitionlawyers.co.uk\/blog\/provisional-finding-in-drug-price-hikes-case","og_locale":"en_GB","og_type":"article","og_title":"Provisional finding in drug price hikes case - Competition Lawyers","og_description":"The UK\u2019s competition regulator has made a provisional finding in the longstanding investigation into drug price hikes, and the outcome is damning.","og_url":"https:\/\/www.competitionlawyers.co.uk\/blog\/provisional-finding-in-drug-price-hikes-case","og_site_name":"Competition Lawyers","article_published_time":"2019-12-04T14:23:55+00:00","og_image":[{"width":725,"height":250,"url":"https:\/\/i2.wp.com\/www.competitionlawyers.co.uk\/blog\/wp-content\/uploads\/2016\/08\/pharmacy_merger_report.png?fit=725%2C250&ssl=1","type":"image\/png"}],"author":"Author","twitter_card":"summary_large_image","twitter_creator":"@Matt","twitter_misc":{"Written by":"Author","Estimated reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.competitionlawyers.co.uk\/blog\/provisional-finding-in-drug-price-hikes-case#article","isPartOf":{"@id":"https:\/\/www.competitionlawyers.co.uk\/blog\/provisional-finding-in-drug-price-hikes-case"},"author":{"name":"Author","@id":"https:\/\/www.competitionlawyers.co.uk\/blog\/#\/schema\/person\/32c18f906b91fed8634e71af54b2a301"},"headline":"Provisional finding in drug price hikes case","datePublished":"2019-12-04T14:23:55+00:00","mainEntityOfPage":{"@id":"https:\/\/www.competitionlawyers.co.uk\/blog\/provisional-finding-in-drug-price-hikes-case"},"wordCount":447,"commentCount":0,"image":{"@id":"https:\/\/www.competitionlawyers.co.uk\/blog\/provisional-finding-in-drug-price-hikes-case#primaryimage"},"thumbnailUrl":"https:\/\/i0.wp.com\/www.competitionlawyers.co.uk\/blog\/wp-content\/uploads\/2016\/08\/pharmacy_merger_report.png?fit=725%2C250&ssl=1","keywords":["cma","competition law","drugs","investigations","Pharmaceuticals","pricing"],"articleSection":["Healthcare","Investigations","Price Hikes"],"inLanguage":"en-GB","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.competitionlawyers.co.uk\/blog\/provisional-finding-in-drug-price-hikes-case#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.competitionlawyers.co.uk\/blog\/provisional-finding-in-drug-price-hikes-case","url":"https:\/\/www.competitionlawyers.co.uk\/blog\/provisional-finding-in-drug-price-hikes-case","name":"Provisional finding in drug price hikes case - Competition Lawyers","isPartOf":{"@id":"https:\/\/www.competitionlawyers.co.uk\/blog\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.competitionlawyers.co.uk\/blog\/provisional-finding-in-drug-price-hikes-case#primaryimage"},"image":{"@id":"https:\/\/www.competitionlawyers.co.uk\/blog\/provisional-finding-in-drug-price-hikes-case#primaryimage"},"thumbnailUrl":"https:\/\/i0.wp.com\/www.competitionlawyers.co.uk\/blog\/wp-content\/uploads\/2016\/08\/pharmacy_merger_report.png?fit=725%2C250&ssl=1","datePublished":"2019-12-04T14:23:55+00:00","author":{"@id":"https:\/\/www.competitionlawyers.co.uk\/blog\/#\/schema\/person\/32c18f906b91fed8634e71af54b2a301"},"description":"The UK\u2019s competition regulator has made a provisional finding in the longstanding investigation into drug price hikes, and the outcome is damning.","breadcrumb":{"@id":"https:\/\/www.competitionlawyers.co.uk\/blog\/provisional-finding-in-drug-price-hikes-case#breadcrumb"},"inLanguage":"en-GB","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.competitionlawyers.co.uk\/blog\/provisional-finding-in-drug-price-hikes-case"]}]},{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/www.competitionlawyers.co.uk\/blog\/provisional-finding-in-drug-price-hikes-case#primaryimage","url":"https:\/\/i0.wp.com\/www.competitionlawyers.co.uk\/blog\/wp-content\/uploads\/2016\/08\/pharmacy_merger_report.png?fit=725%2C250&ssl=1","contentUrl":"https:\/\/i0.wp.com\/www.competitionlawyers.co.uk\/blog\/wp-content\/uploads\/2016\/08\/pharmacy_merger_report.png?fit=725%2C250&ssl=1","width":725,"height":250,"caption":"Pharmaceutical abuse"},{"@type":"BreadcrumbList","@id":"https:\/\/www.competitionlawyers.co.uk\/blog\/provisional-finding-in-drug-price-hikes-case#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.competitionlawyers.co.uk\/blog"},{"@type":"ListItem","position":2,"name":"Provisional finding in drug price hikes case"}]},{"@type":"WebSite","@id":"https:\/\/www.competitionlawyers.co.uk\/blog\/#website","url":"https:\/\/www.competitionlawyers.co.uk\/blog\/","name":"Competition Lawyers","description":"Latest Legal News, Cases & Articles","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.competitionlawyers.co.uk\/blog\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-GB"},{"@type":"Person","@id":"https:\/\/www.competitionlawyers.co.uk\/blog\/#\/schema\/person\/32c18f906b91fed8634e71af54b2a301","name":"Author","image":{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/secure.gravatar.com\/avatar\/6df762ce646241b4e07c2c84d0016582f85c0b3c6f2ce06d0eb5d9aed612cc4e?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/6df762ce646241b4e07c2c84d0016582f85c0b3c6f2ce06d0eb5d9aed612cc4e?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/6df762ce646241b4e07c2c84d0016582f85c0b3c6f2ce06d0eb5d9aed612cc4e?s=96&d=mm&r=g","caption":"Author"},"sameAs":["https:\/\/x.com\/Matt"],"url":"https:\/\/www.competitionlawyers.co.uk\/blog\/author\/matt"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/i0.wp.com\/www.competitionlawyers.co.uk\/blog\/wp-content\/uploads\/2016\/08\/pharmacy_merger_report.png?fit=725%2C250&ssl=1","jetpack-related-posts":[],"jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/www.competitionlawyers.co.uk\/blog\/wp-json\/wp\/v2\/posts\/1110","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.competitionlawyers.co.uk\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.competitionlawyers.co.uk\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.competitionlawyers.co.uk\/blog\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.competitionlawyers.co.uk\/blog\/wp-json\/wp\/v2\/comments?post=1110"}],"version-history":[{"count":1,"href":"https:\/\/www.competitionlawyers.co.uk\/blog\/wp-json\/wp\/v2\/posts\/1110\/revisions"}],"predecessor-version":[{"id":1111,"href":"https:\/\/www.competitionlawyers.co.uk\/blog\/wp-json\/wp\/v2\/posts\/1110\/revisions\/1111"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.competitionlawyers.co.uk\/blog\/wp-json\/wp\/v2\/media\/90"}],"wp:attachment":[{"href":"https:\/\/www.competitionlawyers.co.uk\/blog\/wp-json\/wp\/v2\/media?parent=1110"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.competitionlawyers.co.uk\/blog\/wp-json\/wp\/v2\/categories?post=1110"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.competitionlawyers.co.uk\/blog\/wp-json\/wp\/v2\/tags?post=1110"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}